These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25185888)

  • 21. Financial incentives.
    Silver SE
    Ann Intern Med; 1990 Nov; 113(10):808-9. PubMed ID: 2240892
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues.
    Chaix-Couturier C; Durand-Zaleski I; Jolly D; Durieux P
    Int J Qual Health Care; 2000 Apr; 12(2):133-42. PubMed ID: 10830670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family doctor responses to changes in incentives for influenza immunization under the U.K. Quality and Outcomes Framework pay-for-performance scheme.
    Kontopantelis E; Doran T; Gravelle H; Goudie R; Siciliani L; Sutton M
    Health Serv Res; 2012 Jun; 47(3 Pt 1):1117-36. PubMed ID: 22171997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK.
    Boye KS; Stein D; Matza LS; Jordan J; Yu R; Norrbacka K; Hassan SW; García-Pérez LE
    Drugs R D; 2019 Jun; 19(2):213-225. PubMed ID: 31115873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compliance with quality prescribing indicators in terms of their relationship to financial incentives.
    Fernández Urrusuno R; Montero Balosa MC; Pérez Pérez P; Pascual de la Pisa B
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1845-53. PubMed ID: 23743780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of explicit financial incentives on physician behavior.
    Gupta R; Gupta S
    Arch Intern Med; 2002 Mar; 162(5):612-3. PubMed ID: 11871940
    [No Abstract]   [Full Text] [Related]  

  • 27. Are oncologists' financial incentives aligned with quality care?
    Wong YN
    J Clin Oncol; 2013 Feb; 31(5):517-9. PubMed ID: 23269998
    [No Abstract]   [Full Text] [Related]  

  • 28. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis.
    Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):973-6. PubMed ID: 19621344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of practice size and pay-for-performance incentives with the quality of diabetes management in primary care.
    Vamos EP; Pape UJ; Bottle A; Hamilton FL; Curcin V; Ng A; Molokhia M; Car J; Majeed A; Millett C
    CMAJ; 2011 Sep; 183(12):E809-16. PubMed ID: 21810950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incentive implementation in physician practices: A qualitative study of practice executive perspectives on pay for performance.
    Bokhour BG; Burgess JF; Hook JM; White B; Berlowitz D; Guldin MR; Meterko M; Young GJ
    Med Care Res Rev; 2006 Feb; 63(1 Suppl):73S-95S. PubMed ID: 16688925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The experience of pay for performance in English family practice: a qualitative study.
    Campbell SM; McDonald R; Lester H
    Ann Fam Med; 2008; 6(3):228-34. PubMed ID: 18474885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inequalities in glycemic management in people living with type 2 diabetes mellitus and severe mental illnesses: cohort study from the UK over 10 years.
    Das-Munshi J; Schofield P; Ashworth M; Gaughran F; Hull S; Ismail K; Robson J; Stewart R; Mathur R
    BMJ Open Diabetes Res Care; 2021 Sep; 9(1):. PubMed ID: 34497046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using compensation to improve primary care.
    Holm CE; Lipsky MS
    Med Group Manage J; 1999; 46(4):20-6. PubMed ID: 10539642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending.
    Metes ID; Xue L; Chang CH; Huskamp HA; Gellad WF; Lo-Ciganic WH; Choudhry NK; Richards-Shubik S; Guclu H; Donohue JM
    BMC Health Serv Res; 2019 Oct; 19(1):703. PubMed ID: 31619229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance-based financial incentives for diabetes care: an effective strategy?
    Latham LP; Marshall EG
    Can J Diabetes; 2015 Feb; 39(1):83-7. PubMed ID: 25444683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician pay-for-performance. Implementation and research issues.
    Christianson JB; Knutson DJ; Mazze RS
    J Gen Intern Med; 2006 Feb; 21 Suppl 2(Suppl 2):S9-S13. PubMed ID: 16637965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.
    Cook MN; Girman CJ; Stein PP; Alexander CM
    Diabet Med; 2007 Apr; 24(4):350-8. PubMed ID: 17335466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of explicit financial incentives on physician behavior.
    Armour BS; Pitts MM; Maclean R; Cangialose C; Kishel M; Imai H; Etchason J
    Arch Intern Med; 2001 May; 161(10):1261-6. PubMed ID: 11371253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timings for HbA
    Hirst JA; Farmer AJ; Smith MC; Stevens RJ
    Diabet Med; 2019 Jan; 36(1):36-43. PubMed ID: 30175871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.